Perjeta (Pertuzumab) Medicine
Generic name : Pertuzumab.
Trade name : Perjeta.
Manufacturer information :
Perjeta is manufactured by Genentech.
Perjeta FDA Approval :
Perjeta first approvedJune 8th, 2012.
Perjeta Dosage form :
420 mg/14 mL single-use vial.
Perjeta Indications and Usage :
Metastatic Breast Cancer
Indicated in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer in patients who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.
Perjeta (Pertuzumab) availability in India
- You could import this medicine against import permit on Patient Name.
- Please contact ACT Lifesciences Private Limited for further information.